Stephen J. Tulipano, CPA

Stephen J. Tulipano, CPA

Chief Financial OfficeratStoke Therapeutics· In proxies 2022–2023

Pay in FY2023-31% from the year before · Stoke Therapeutics stock -43.0% the same year

Stephen J. Tulipano, CPA was paid $1.6M in FY2023 (Dec), down 31%. Stoke Therapeutics stock fell 43.0% that year.

Pay$100 in the stock at the end of FY21 → $22
Pay is from the Summary Compensation Table of each Stoke Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Stoke TherapeuticsPublic company · 4 yr
    • Chief Financial Officer2022 – Present · 4 yrStock in role +20%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?